Drug Shortage Report for NAT-ESCITALOPRAM

Last updated on 2020-10-26 History
Report ID 75793
Drug Identification Number 02440296
Brand name NAT-ESCITALOPRAM
Common or Proper name Escitalopram Tablets
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) ESCITALOPRAM
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-06-30
Actual start date
Estimated end date Unknown
Actual end date 2020-10-05
Shortage status Resolved
Updated date 2020-10-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-10-26 French Compare
v8 2020-10-26 English Compare
v7 2019-07-01 English Compare
v6 2019-04-17 French Compare
v5 2019-04-17 English Compare
v4 2019-02-15 French Compare
v3 2019-02-15 English Compare
v2 2019-02-15 French Compare
v1 2019-02-15 English Compare

Showing 1 to 9 of 9